Princeton Alpha Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Princeton Alpha Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,305	Closed	-$578K	–	648
2016 Q4	$578K	Buy	+5,305	New	+$591K	0.12%	279
2015 Q3	–	Sell	-2,938	Closed	-$517K	–	814
2015 Q2	$517K	Sell	2,938 -387	-12%	-$69.5K	0.1%	296
2015 Q1	$575K	Buy	+3,325	New	+$571K	0.12%	235
2014 Q2	–	Sell	-2,882	Closed	-$400K	–	771
2014 Q1	$400K	Buy	+2,882	New	+$434K	0.12%	249

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Princeton Alpha Management's JAZZ Position: Q1 2017 in Review

Princeton Alpha Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2017, closing a stake of 5,305 shares — an estimated $578K sold.

Princeton Alpha Management first reported a position in JAZZ in Q1 2014 and held it in 4 quarters. The position peaked at $578K in Q4 2016. 306 funds tracked by Wall St. Rank hold JAZZ as of Q1 2017.

Princeton Alpha Management reported no remaining Jazz Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Princeton Alpha Management sold 5,305 Jazz Pharmaceuticals shares in Q1 2017, an estimated $578K.
Princeton Alpha Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 4 quarters.
Princeton Alpha Management's Jazz Pharmaceuticals position peaked at $578K in Q4 2016.
306 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2017.

Based on Princeton Alpha Management's 13F filing for Q1 2017, filed 3 May 2017.